

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sodium-independent organic anion transport (GO:0043252) | 6.65125137 |
| 2 | neuron fate determination (GO:0048664) | 6.44197731 |
| 3 | snRNA transcription (GO:0009301) | 5.94859729 |
| 4 | regulation of transmission of nerve impulse (GO:0051969) | 5.79633235 |
| 5 | aggressive behavior (GO:0002118) | 5.63275168 |
| 6 | cell proliferation involved in metanephros development (GO:0072203) | 5.24778199 |
| 7 | alkaloid metabolic process (GO:0009820) | 5.18982685 |
| 8 | regulation of female receptivity (GO:0045924) | 5.11737091 |
| 9 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.82493446 |
| 10 | inositol metabolic process (GO:0006020) | 4.79690048 |
| 11 | cellular response to cholesterol (GO:0071397) | 4.78430903 |
| 12 | cellular response to ethanol (GO:0071361) | 4.64143121 |
| 13 | I-kappaB phosphorylation (GO:0007252) | 4.46920073 |
| 14 | microtubule severing (GO:0051013) | 4.45782618 |
| 15 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.42588251 |
| 16 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.41955018 |
| 17 | cell proliferation involved in kidney development (GO:0072111) | 4.40302406 |
| 18 | sequestering of actin monomers (GO:0042989) | 4.36787943 |
| 19 | female mating behavior (GO:0060180) | 4.21821318 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.21248913 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.21248913 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.21248913 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.21248913 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.21248913 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.21248913 |
| 26 | DNA topological change (GO:0006265) | 4.17919430 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 4.14362799 |
| 28 | peristalsis (GO:0030432) | 4.11647185 |
| 29 | regulation of necroptotic process (GO:0060544) | 4.10401080 |
| 30 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.09770827 |
| 31 | maternal behavior (GO:0042711) | 4.04340918 |
| 32 | sulfation (GO:0051923) | 4.03592965 |
| 33 | nucleotide salvage (GO:0043173) | 3.98946905 |
| 34 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.98807457 |
| 35 | detection of molecule of bacterial origin (GO:0032490) | 3.94133881 |
| 36 | grooming behavior (GO:0007625) | 3.88536676 |
| 37 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.82730006 |
| 38 | negative regulation of necroptotic process (GO:0060546) | 3.77080438 |
| 39 | somite development (GO:0061053) | 3.68393556 |
| 40 | neural tube formation (GO:0001841) | 3.65799895 |
| 41 | neuron fate specification (GO:0048665) | 3.64506629 |
| 42 | NAD biosynthetic process (GO:0009435) | 3.62433364 |
| 43 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.58436122 |
| 44 | negative regulation of interleukin-17 production (GO:0032700) | 3.57326085 |
| 45 | parental behavior (GO:0060746) | 3.56984519 |
| 46 | positive regulation of amino acid transport (GO:0051957) | 3.53938324 |
| 47 | response to cholesterol (GO:0070723) | 3.52141785 |
| 48 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.51647054 |
| 49 | cellular response to sterol (GO:0036315) | 3.48914166 |
| 50 | protein kinase C signaling (GO:0070528) | 3.41750799 |
| 51 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.38906348 |
| 52 | behavioral response to nicotine (GO:0035095) | 3.37645750 |
| 53 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.37372426 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 3.37267909 |
| 55 | post-anal tail morphogenesis (GO:0036342) | 3.34739484 |
| 56 | renal system development (GO:0072001) | 3.30134612 |
| 57 | hyperosmotic salinity response (GO:0042538) | 3.27622903 |
| 58 | positive regulation of T cell cytokine production (GO:0002726) | 3.25641077 |
| 59 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.19711671 |
| 60 | cellular anion homeostasis (GO:0030002) | 3.19226765 |
| 61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19024492 |
| 62 | positive regulation of RNA splicing (GO:0033120) | 3.16459814 |
| 63 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.15983770 |
| 64 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.15022090 |
| 65 | regulation of DNA damage checkpoint (GO:2000001) | 3.13511664 |
| 66 | protein prenylation (GO:0018342) | 3.13373192 |
| 67 | prenylation (GO:0097354) | 3.13373192 |
| 68 | thrombin receptor signaling pathway (GO:0070493) | 3.13108393 |
| 69 | response to host immune response (GO:0052572) | 3.12442487 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12442487 |
| 71 | hemoglobin metabolic process (GO:0020027) | 3.11559163 |
| 72 | negative regulation of defense response to virus (GO:0050687) | 3.05466644 |
| 73 | endosome to lysosome transport (GO:0008333) | 3.05435937 |
| 74 | layer formation in cerebral cortex (GO:0021819) | 2.98329969 |
| 75 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.95563376 |
| 76 | actin nucleation (GO:0045010) | 2.95219651 |
| 77 | corticosteroid receptor signaling pathway (GO:0031958) | 2.92159021 |
| 78 | negative regulation of necrotic cell death (GO:0060547) | 2.89906326 |
| 79 | embryonic heart tube development (GO:0035050) | 2.85657570 |
| 80 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.85613641 |
| 81 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.85613641 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81032198 |
| 83 | organic cation transport (GO:0015695) | 2.80364160 |
| 84 | response to sterol (GO:0036314) | 2.78515679 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.78124897 |
| 86 | response to host (GO:0075136) | 2.78124897 |
| 87 | response to host defenses (GO:0052200) | 2.78124897 |
| 88 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77884650 |
| 89 | embryonic camera-type eye development (GO:0031076) | 2.77657467 |
| 90 | positive regulation of epidermis development (GO:0045684) | 2.74291543 |
| 91 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.73669933 |
| 92 | negative regulation of neurological system process (GO:0031645) | 2.73534819 |
| 93 | neuron remodeling (GO:0016322) | 2.71273364 |
| 94 | mesonephros development (GO:0001823) | 2.70731129 |
| 95 | dendritic spine morphogenesis (GO:0060997) | 2.70166839 |
| 96 | auditory behavior (GO:0031223) | 2.66935327 |
| 97 | cholesterol catabolic process (GO:0006707) | 2.66583491 |
| 98 | sterol catabolic process (GO:0016127) | 2.66583491 |
| 99 | protein import into peroxisome matrix (GO:0016558) | 2.64303047 |
| 100 | regulation of histone H3-K9 methylation (GO:0051570) | 2.61314225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.18118679 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.00965854 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.02851835 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.17947864 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.62156255 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51444468 |
| 7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.44656774 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.44656774 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.44656774 |
| 10 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.33729352 |
| 11 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 2.20223738 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 12.5182550 |
| 13 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.96743818 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94441283 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62991147 |
| 16 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.60752131 |
| 17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.57081242 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56481545 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 1.50968778 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49017728 |
| 21 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44404476 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43559506 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42940043 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41283603 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35633404 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35261585 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32992364 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31749814 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29764423 |
| 30 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.28527948 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24211923 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21445172 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20970046 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20815104 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19101458 |
| 36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18384760 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17949551 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17944708 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16345519 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14582331 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.13711765 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11648380 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09883993 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09728877 |
| 45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.09403139 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09246350 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08527285 |
| 48 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00232282 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97410581 |
| 50 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95826640 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94572698 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94331931 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.93527936 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91523664 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90441811 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.90172981 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 0.89028588 |
| 58 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86902229 |
| 59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84886310 |
| 60 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84823675 |
| 61 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84506952 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84506952 |
| 63 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.84231346 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83959657 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 0.83719397 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83694248 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83327277 |
| 68 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.82815836 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81601477 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79888481 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78475321 |
| 72 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.78015239 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.76219467 |
| 74 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.75316414 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.74023720 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72688252 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71351306 |
| 78 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.71237491 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70471683 |
| 80 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.70260861 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69954082 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.69898234 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69220884 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.68662455 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.67932953 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.67875225 |
| 87 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.67424183 |
| 88 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67327292 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67027611 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.66791261 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.66394144 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65615476 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.65435128 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.64960203 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64677053 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.64564674 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64164620 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.63445880 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63140540 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.62003579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002638_abnormal_pupillary_reflex | 5.33889866 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 4.83844632 |
| 3 | MP0000383_abnormal_hair_follicle | 3.68509065 |
| 4 | MP0005187_abnormal_penis_morphology | 3.07036069 |
| 5 | MP0010307_abnormal_tumor_latency | 3.04475023 |
| 6 | MP0000538_abnormal_urinary_bladder | 2.88183745 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.85221709 |
| 8 | MP0008057_abnormal_DNA_replication | 2.83009999 |
| 9 | MP0002089_abnormal_postnatal_growth/wei | 2.79670349 |
| 10 | MP0003122_maternal_imprinting | 2.73462074 |
| 11 | MP0004134_abnormal_chest_morphology | 2.58790784 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.31012499 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.18856529 |
| 14 | MP0010678_abnormal_skin_adnexa | 2.08894392 |
| 15 | MP0005503_abnormal_tendon_morphology | 2.08216732 |
| 16 | MP0003111_abnormal_nucleus_morphology | 1.87602178 |
| 17 | MP0002928_abnormal_bile_duct | 1.84120242 |
| 18 | MP0003252_abnormal_bile_duct | 1.79116050 |
| 19 | MP0003959_abnormal_lean_body | 1.78910292 |
| 20 | MP0000534_abnormal_ureter_morphology | 1.76025620 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.75485956 |
| 22 | MP0003868_abnormal_feces_composition | 1.74325710 |
| 23 | MP0000003_abnormal_adipose_tissue | 1.73255773 |
| 24 | MP0002932_abnormal_joint_morphology | 1.57464971 |
| 25 | MP0001853_heart_inflammation | 1.56707046 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.52994585 |
| 27 | MP0000733_abnormal_muscle_development | 1.52545802 |
| 28 | MP0002108_abnormal_muscle_morphology | 1.47150230 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.40470005 |
| 30 | MP0005220_abnormal_exocrine_pancreas | 1.40259536 |
| 31 | MP0003646_muscle_fatigue | 1.39377177 |
| 32 | MP0003283_abnormal_digestive_organ | 1.39367119 |
| 33 | MP0003123_paternal_imprinting | 1.36463255 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.31133326 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.31133326 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.30395173 |
| 37 | MP0004142_abnormal_muscle_tone | 1.29690689 |
| 38 | MP0003303_peritoneal_inflammation | 1.20444370 |
| 39 | MP0002405_respiratory_system_inflammati | 1.19448434 |
| 40 | MP0003121_genomic_imprinting | 1.18691912 |
| 41 | MP0002163_abnormal_gland_morphology | 1.15598135 |
| 42 | MP0004381_abnormal_hair_follicle | 1.13673821 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.13362230 |
| 44 | MP0002938_white_spotting | 1.12679101 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.10328720 |
| 46 | MP0009785_altered_susceptibility_to | 1.10323149 |
| 47 | MP0000639_abnormal_adrenal_gland | 1.04957239 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.04261838 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.03634720 |
| 50 | MP0003195_calcinosis | 1.03248881 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.02449913 |
| 52 | MP0002822_catalepsy | 1.02394430 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.02004083 |
| 54 | MP0009764_decreased_sensitivity_to | 1.01546471 |
| 55 | MP0003828_pulmonary_edema | 0.98826208 |
| 56 | MP0000647_abnormal_sebaceous_gland | 0.98518540 |
| 57 | MP0009115_abnormal_fat_cell | 0.98383733 |
| 58 | MP0002098_abnormal_vibrissa_morphology | 0.95679136 |
| 59 | MP0005025_abnormal_response_to | 0.95071113 |
| 60 | MP0001915_intracranial_hemorrhage | 0.94450518 |
| 61 | MP0005375_adipose_tissue_phenotype | 0.93161230 |
| 62 | MP0001270_distended_abdomen | 0.91693357 |
| 63 | MP0002114_abnormal_axial_skeleton | 0.91572879 |
| 64 | MP0001188_hyperpigmentation | 0.89871767 |
| 65 | MP0010155_abnormal_intestine_physiology | 0.86003263 |
| 66 | MP0000516_abnormal_urinary_system | 0.82966222 |
| 67 | MP0005367_renal/urinary_system_phenotyp | 0.82966222 |
| 68 | MP0000490_abnormal_crypts_of | 0.81612812 |
| 69 | MP0004270_analgesia | 0.81076702 |
| 70 | MP0000428_abnormal_craniofacial_morphol | 0.80098077 |
| 71 | MP0002168_other_aberrant_phenotype | 0.79518129 |
| 72 | MP0000371_diluted_coat_color | 0.78043091 |
| 73 | MP0009697_abnormal_copulation | 0.71854523 |
| 74 | MP0002736_abnormal_nociception_after | 0.71149753 |
| 75 | MP0005000_abnormal_immune_tolerance | 0.69296574 |
| 76 | MP0005621_abnormal_cell_physiology | 0.68987564 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.68811553 |
| 78 | MP0001800_abnormal_humoral_immune | 0.68367045 |
| 79 | MP0002419_abnormal_innate_immunity | 0.67531516 |
| 80 | MP0001905_abnormal_dopamine_level | 0.66865543 |
| 81 | MP0003632_abnormal_nervous_system | 0.64294327 |
| 82 | MP0002723_abnormal_immune_serum | 0.64263603 |
| 83 | MP0002722_abnormal_immune_system | 0.63728700 |
| 84 | MP0005369_muscle_phenotype | 0.62914231 |
| 85 | MP0004233_abnormal_muscle_weight | 0.60592407 |
| 86 | MP0009278_abnormal_bone_marrow | 0.60159973 |
| 87 | MP0008469_abnormal_protein_level | 0.59988675 |
| 88 | MP0003724_increased_susceptibility_to | 0.59924714 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.59916703 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.59915259 |
| 91 | MP0002106_abnormal_muscle_physiology | 0.59588764 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.58719688 |
| 93 | MP0005334_abnormal_fat_pad | 0.58495992 |
| 94 | MP0001819_abnormal_immune_cell | 0.57965426 |
| 95 | MP0005451_abnormal_body_composition | 0.57432478 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.57368652 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.56743036 |
| 98 | MP0003115_abnormal_respiratory_system | 0.55993211 |
| 99 | MP0003866_abnormal_defecation | 0.55746701 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.54699827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deformed sella turcica (HP:0002681) | 5.14512944 |
| 2 | Broad face (HP:0000283) | 4.82306143 |
| 3 | Abnormality of the sella turcica (HP:0002679) | 4.72952415 |
| 4 | Neoplasm of the heart (HP:0100544) | 4.59798550 |
| 5 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 4.57683897 |
| 6 | Short 4th metacarpal (HP:0010044) | 4.57683897 |
| 7 | Spontaneous abortion (HP:0005268) | 4.05345983 |
| 8 | Supernumerary bones of the axial skeleton (HP:0009144) | 3.93413723 |
| 9 | Large earlobe (HP:0009748) | 3.92317767 |
| 10 | Abnormality of the parietal bone (HP:0002696) | 3.74035020 |
| 11 | Poor eye contact (HP:0000817) | 3.73643419 |
| 12 | Abnormality of the nasal septum (HP:0000419) | 3.66389410 |
| 13 | Thrombocytosis (HP:0001894) | 3.58584775 |
| 14 | Vertebral arch anomaly (HP:0008438) | 3.56740361 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.56528704 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.56528704 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.56528704 |
| 18 | Supernumerary ribs (HP:0005815) | 3.49311908 |
| 19 | Down-sloping shoulders (HP:0200021) | 3.19514148 |
| 20 | Short phalanx of the thumb (HP:0009660) | 3.16823154 |
| 21 | Split foot (HP:0001839) | 3.13918225 |
| 22 | Cutaneous melanoma (HP:0012056) | 3.10031152 |
| 23 | Abnormality of the 4th metacarpal (HP:0010012) | 3.07289792 |
| 24 | Medulloblastoma (HP:0002885) | 3.06641091 |
| 25 | Abnormality of the lumbar spine (HP:0100712) | 3.05351458 |
| 26 | Diastasis recti (HP:0001540) | 3.04672305 |
| 27 | Depressed nasal tip (HP:0000437) | 2.98090361 |
| 28 | Urethral obstruction (HP:0000796) | 2.98077451 |
| 29 | Flat occiput (HP:0005469) | 2.91976066 |
| 30 | Hemiplegia (HP:0002301) | 2.84832193 |
| 31 | Thoracolumbar scoliosis (HP:0002944) | 2.80881681 |
| 32 | Flat acetabular roof (HP:0003180) | 2.75909979 |
| 33 | Abnormal social behavior (HP:0012433) | 2.69377337 |
| 34 | Impaired social interactions (HP:0000735) | 2.69377337 |
| 35 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.66648370 |
| 36 | 11 pairs of ribs (HP:0000878) | 2.62680132 |
| 37 | Short nail (HP:0001799) | 2.61026426 |
| 38 | Abnormal number of incisors (HP:0011064) | 2.58831232 |
| 39 | Milia (HP:0001056) | 2.56441859 |
| 40 | Hyperventilation (HP:0002883) | 2.51761697 |
| 41 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.50771430 |
| 42 | Broad ribs (HP:0000885) | 2.42851462 |
| 43 | Neoplasm of the oral cavity (HP:0100649) | 2.38122312 |
| 44 | Glioma (HP:0009733) | 2.35428800 |
| 45 | Gingival bleeding (HP:0000225) | 2.34924166 |
| 46 | Nonimmune hydrops fetalis (HP:0001790) | 2.32169891 |
| 47 | Abnormal ossification of hand bones (HP:0005921) | 2.29848252 |
| 48 | Vitreoretinal degeneration (HP:0000655) | 2.26970496 |
| 49 | Hemiparesis (HP:0001269) | 2.26949056 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.26262110 |
| 51 | Subacute progressive viral hepatitis (HP:0006572) | 2.24216230 |
| 52 | Thoracic kyphosis (HP:0002942) | 2.23897279 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.23201333 |
| 54 | Pigmentary retinal degeneration (HP:0001146) | 2.19987997 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19864001 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19864001 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19864001 |
| 58 | Midline defect of the nose (HP:0004122) | 2.18935846 |
| 59 | Viral hepatitis (HP:0006562) | 2.17559658 |
| 60 | Trigonocephaly (HP:0000243) | 2.16718536 |
| 61 | Arterial thrombosis (HP:0004420) | 2.10858145 |
| 62 | Flared iliac wings (HP:0002869) | 2.10560321 |
| 63 | Median cleft lip (HP:0000161) | 2.10206906 |
| 64 | Progressive microcephaly (HP:0000253) | 2.09367092 |
| 65 | Severe global developmental delay (HP:0011344) | 2.09088105 |
| 66 | Fibular hypoplasia (HP:0003038) | 2.08779794 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.08325266 |
| 68 | Clumsiness (HP:0002312) | 2.08120605 |
| 69 | Macroorchidism (HP:0000053) | 2.06932263 |
| 70 | Abnormal hand bone ossification (HP:0010660) | 2.03805150 |
| 71 | Meningioma (HP:0002858) | 2.03475579 |
| 72 | Long eyelashes (HP:0000527) | 2.03246578 |
| 73 | Wide nose (HP:0000445) | 2.03000304 |
| 74 | Thrombophlebitis (HP:0004418) | 2.01767149 |
| 75 | J-shaped sella turcica (HP:0002680) | 2.01721326 |
| 76 | Bilateral microphthalmos (HP:0007633) | 1.99218412 |
| 77 | Acanthocytosis (HP:0001927) | 1.98617178 |
| 78 | Dislocated radial head (HP:0003083) | 1.98301302 |
| 79 | Palpebral edema (HP:0100540) | 1.97770583 |
| 80 | Absent speech (HP:0001344) | 1.97355527 |
| 81 | Protruding tongue (HP:0010808) | 1.92791576 |
| 82 | Periodontitis (HP:0000704) | 1.86753937 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86391714 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86391714 |
| 85 | Abnormality of the periventricular white matter (HP:0002518) | 1.84749203 |
| 86 | Skin pits (HP:0100276) | 1.83996767 |
| 87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.83131968 |
| 88 | Poikilocytosis (HP:0004447) | 1.81980082 |
| 89 | Portal hypertension (HP:0001409) | 1.81603087 |
| 90 | Cerebellar dysplasia (HP:0007033) | 1.80209615 |
| 91 | Non-midline cleft lip (HP:0100335) | 1.78077997 |
| 92 | Chest pain (HP:0100749) | 1.77289132 |
| 93 | Craniofacial hyperostosis (HP:0004493) | 1.76650497 |
| 94 | Hepatoblastoma (HP:0002884) | 1.76504167 |
| 95 | Beaking of vertebral bodies (HP:0004568) | 1.75541738 |
| 96 | Submucous cleft hard palate (HP:0000176) | 1.73213966 |
| 97 | Increased serum ferritin (HP:0003281) | 1.71091325 |
| 98 | Epistaxis (HP:0000421) | 1.70350907 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 1.70141615 |
| 100 | Abnormality of the hepatic vasculature (HP:0006707) | 1.70130671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.25991444 |
| 2 | SCYL2 | 5.50621968 |
| 3 | STK4 | 3.48079512 |
| 4 | TLK1 | 3.32899778 |
| 5 | NUAK1 | 2.47826148 |
| 6 | CAMK1D | 2.35223371 |
| 7 | MAP3K8 | 2.29097774 |
| 8 | KDR | 2.25419201 |
| 9 | CDK12 | 2.20438653 |
| 10 | MAP2K3 | 2.19820359 |
| 11 | BRD4 | 1.92733485 |
| 12 | IKBKE | 1.91732541 |
| 13 | ZAK | 1.83472342 |
| 14 | FRK | 1.78313902 |
| 15 | CAMK1G | 1.73458503 |
| 16 | SGK2 | 1.73075531 |
| 17 | BLK | 1.70634929 |
| 18 | DYRK3 | 1.60299870 |
| 19 | PRPF4B | 1.54602354 |
| 20 | IRAK4 | 1.34349200 |
| 21 | MAP3K3 | 1.30886893 |
| 22 | BCKDK | 1.28390413 |
| 23 | SGK3 | 1.27359664 |
| 24 | SGK494 | 1.24492390 |
| 25 | SGK223 | 1.24492390 |
| 26 | TAOK3 | 1.18804056 |
| 27 | MAP3K1 | 1.15726820 |
| 28 | CASK | 1.11185726 |
| 29 | LATS1 | 1.11010639 |
| 30 | MAP3K14 | 1.08451637 |
| 31 | AKT3 | 0.99451676 |
| 32 | WNK1 | 0.98688066 |
| 33 | HIPK2 | 0.96464768 |
| 34 | MAP3K13 | 0.94025214 |
| 35 | PRKAA1 | 0.93673895 |
| 36 | CDC42BPA | 0.91964202 |
| 37 | MAP3K7 | 0.86520876 |
| 38 | RPS6KB2 | 0.86393311 |
| 39 | SGK1 | 0.85544966 |
| 40 | TBK1 | 0.81655463 |
| 41 | RPS6KA4 | 0.81386117 |
| 42 | SIK2 | 0.78807706 |
| 43 | FGFR3 | 0.77573547 |
| 44 | CSK | 0.75285830 |
| 45 | RPS6KA2 | 0.74573944 |
| 46 | TRIB3 | 0.73620886 |
| 47 | CHUK | 0.72811428 |
| 48 | MAP2K6 | 0.72451990 |
| 49 | IRAK2 | 0.70814578 |
| 50 | EEF2K | 0.69570849 |
| 51 | CAMKK2 | 0.68365999 |
| 52 | MATK | 0.67717577 |
| 53 | CSF1R | 0.63923137 |
| 54 | AURKB | 0.63753371 |
| 55 | MTOR | 0.61815889 |
| 56 | PRKAA2 | 0.61797207 |
| 57 | IRAK1 | 0.61580458 |
| 58 | PRKG1 | 0.60354674 |
| 59 | LRRK2 | 0.58649623 |
| 60 | CDK4 | 0.57512134 |
| 61 | FGFR4 | 0.57461902 |
| 62 | ICK | 0.56271680 |
| 63 | FGR | 0.55149430 |
| 64 | RPS6KA5 | 0.53919350 |
| 65 | GRK6 | 0.53755552 |
| 66 | CAMK4 | 0.52510937 |
| 67 | TAF1 | 0.51572472 |
| 68 | STK16 | 0.51080743 |
| 69 | ATR | 0.48106673 |
| 70 | ADRBK2 | 0.47892443 |
| 71 | TIE1 | 0.47663730 |
| 72 | MAPK3 | 0.47134171 |
| 73 | PRKCQ | 0.47125262 |
| 74 | TNIK | 0.45562664 |
| 75 | PKN2 | 0.43732139 |
| 76 | STK38 | 0.42659845 |
| 77 | ADRBK1 | 0.41655400 |
| 78 | FGFR2 | 0.41275121 |
| 79 | RPS6KA6 | 0.41051570 |
| 80 | AKT1 | 0.40922186 |
| 81 | GRK7 | 0.40415356 |
| 82 | BMPR1B | 0.39184058 |
| 83 | CAMKK1 | 0.39062089 |
| 84 | TRPM7 | 0.37502093 |
| 85 | SYK | 0.37198835 |
| 86 | MAP3K2 | 0.36954843 |
| 87 | CDK2 | 0.36792023 |
| 88 | AURKA | 0.36773026 |
| 89 | FES | 0.34975492 |
| 90 | TESK2 | 0.34759135 |
| 91 | RPS6KC1 | 0.32784413 |
| 92 | RPS6KL1 | 0.32784413 |
| 93 | TYRO3 | 0.32649902 |
| 94 | GSK3A | 0.32625833 |
| 95 | OBSCN | 0.32072768 |
| 96 | STK11 | 0.31692959 |
| 97 | CDK3 | 0.30693660 |
| 98 | TTN | 0.29958481 |
| 99 | MAPKAPK3 | 0.29556718 |
| 100 | ZAP70 | 0.29439399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 4.58682038 |
| 2 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 3.50098036 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.01625013 |
| 4 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.94001144 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59132887 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.19128564 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.05530466 |
| 8 | Alcoholism_Homo sapiens_hsa05034 | 1.97227755 |
| 9 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.89761209 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.70690429 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57697453 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55504400 |
| 13 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.55384561 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.50507720 |
| 15 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.46223980 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33972087 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.32881415 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29955528 |
| 19 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.27034684 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26349781 |
| 21 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14991093 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12424825 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10826049 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06104406 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05268673 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.04571455 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.04486602 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02904936 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02688523 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01463386 |
| 31 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97694526 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97590987 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97454998 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94121961 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92427021 |
| 36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88542907 |
| 37 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.86324790 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86289619 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84420609 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 0.83548530 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83344097 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82681012 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82035715 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81890520 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81658706 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 0.81490735 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.79241495 |
| 48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78896014 |
| 49 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77309264 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77231665 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 0.76269595 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74804011 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74532181 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74368373 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70009319 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69813012 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.69493014 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69464579 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69074099 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68564886 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67774979 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67448871 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66922948 |
| 64 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.66708840 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66691221 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66610532 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.64901428 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.63736781 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63516982 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.63186952 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.62492739 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60933011 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59871946 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59600199 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59307108 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59306242 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58581980 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57428413 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57101342 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55851154 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53388061 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53025953 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52005547 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51998900 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.51902503 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51650505 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.51594011 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51348690 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51155712 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47821354 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47473856 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47278580 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.47079158 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46897071 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.46529947 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46438964 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44563448 |
| 98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44124601 |
| 99 | Cell cycle_Homo sapiens_hsa04110 | 0.41188512 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41051434 |

